Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $2.19 Million - $3.11 Million
-38,649 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$86.23 - $125.19 $1.49 Million - $2.17 Million
17,329 Added 81.28%
38,649 $2.28 Million
Q4 2020

Jan 29, 2021

BUY
$79.17 - $111.47 $1.69 Million - $2.38 Million
21,320 New
21,320 $2.29 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $376M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Paradiem, LLC Portfolio

Follow Paradiem, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradiem, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradiem, LLC with notifications on news.